VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome

NCT01130246 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5189

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of efficacy

Conditions

Acute Coronary Syndrome

Interventions

DRUG: A-002, varespladib methyl
DRUG: Placebo

Sponsor

Anthera Pharmaceuticals